Skip to main navigation

Investors
News
- News Releases
- News and Mentions
Presentations & Events
- Presentations
- Events
Stock Performance
- Stock Information
- Analyst Coverage
Financials & Filings
- SEC Filings
- Quarterly Results
Corporate Governance
Resources

News Releases

Year

Aug 08 / 24

Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Aug 05 / 24

Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results

Jul 08 / 24

Belite Bio to Present at the JonesHealthcare Seaside Summit

Jun 18 / 24

Belite Bio Receives Approval to Initiate a Second Stargardt Disease Clinical Trial in the United Kingdom

Jun 12 / 24

Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan

May 14 / 24

Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference

May 13 / 24

Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update

May 13 / 24

Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

May 08 / 24

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Next page
Last page

Displaying 10 - 18 of 32

Belite Bio™ Inc
12750 High Bluff Drive Suite 475,
San Diego CA, 92130 USA

Join our mailing list.

Sign up to receive important updates and news from Belite Bio